Expression of the Insulin-like Growth Factor-1 Receptor in Odontogenic Myxoma
Standard
Expression of the Insulin-like Growth Factor-1 Receptor in Odontogenic Myxoma. / Friedrich, Reinhard E; Hagel, Christian; Zustin, Jozef.
in: ANTICANCER RES, Jahrgang 36, Nr. 6, 06.2016, S. 3103-7.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Expression of the Insulin-like Growth Factor-1 Receptor in Odontogenic Myxoma
AU - Friedrich, Reinhard E
AU - Hagel, Christian
AU - Zustin, Jozef
N1 - Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
PY - 2016/6
Y1 - 2016/6
N2 - UNLABELLED: Odontogenic myxoma (OM) is a rare mesenchymal tumour arising in the jaws. The origin and pathogenesis of OM is poorly understood. The aim of this study was to characterize OM by immunolocalization of certain antigens in the tumour that are relevant for cellular differentiation, migration and maintenance.MATERIALS AND METHODS: Five OMs were immunohistochemically investigated for expression of nestin, CD133, podoplanin, and insulin-like growth factor 1 receptor (IGF-1R).RESULTS: OM failed to react with antibodies applied in this study, with the exception of IGF-1R in tumour cells.DISCUSSION: OM is a poorly characterized benign, invasive tumour of the jaws. The absence of stem cell marker in OM does not exclude possible temporary expression of these antigens during certain phases of tumour development. The identification of IGF-1R in OM is shared with numerous tumours and indicates the ability of these tumour cells to respond to growth factors.
AB - UNLABELLED: Odontogenic myxoma (OM) is a rare mesenchymal tumour arising in the jaws. The origin and pathogenesis of OM is poorly understood. The aim of this study was to characterize OM by immunolocalization of certain antigens in the tumour that are relevant for cellular differentiation, migration and maintenance.MATERIALS AND METHODS: Five OMs were immunohistochemically investigated for expression of nestin, CD133, podoplanin, and insulin-like growth factor 1 receptor (IGF-1R).RESULTS: OM failed to react with antibodies applied in this study, with the exception of IGF-1R in tumour cells.DISCUSSION: OM is a poorly characterized benign, invasive tumour of the jaws. The absence of stem cell marker in OM does not exclude possible temporary expression of these antigens during certain phases of tumour development. The identification of IGF-1R in OM is shared with numerous tumours and indicates the ability of these tumour cells to respond to growth factors.
M3 - SCORING: Journal article
C2 - 27272834
VL - 36
SP - 3103
EP - 3107
JO - ANTICANCER RES
JF - ANTICANCER RES
SN - 0250-7005
IS - 6
ER -